Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kane Biotech Inc (KNE.VN)

Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 13,184
  • Shares Outstanding, K 131,845
  • Annual Sales, $ 2,668 K
  • Annual Income, $ -3,890 K
  • 60-Month Beta 0.41
  • Price/Sales 4.61
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade KNE.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date 04/18/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.090 +11.11%
on 03/14/24
0.110 -9.09%
on 03/22/24
-0.005 (-4.76%)
since 02/28/24
3-Month
0.070 +42.86%
on 01/10/24
0.120 -16.67%
on 02/21/24
+0.015 (+17.65%)
since 12/28/23
52-Week
0.050 +100.00%
on 10/10/23
0.140 -28.57%
on 05/25/23
-0.020 (-16.67%)
since 03/28/23

Most Recent Stories

More News
Kane Biotech Announces Adoption of Amended and Restated Stock Option Plan and Performance and Restricted Share Unit Plan

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, June 30, 2022 (GLOBE NEWSWIRE) -- Kane Biotech...

KNBIF : 0.0718 (-8.65%)
KNE.VN : 0.100 (unch)
Kane Biotech Announces Amended Credit Facility

WINNIPEG, Manitoba, June 15, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that...

KNE.VN : 0.100 (unch)
KNBIF : 0.0718 (-8.65%)
Kane Biotech Announces First Quarter 2022 Financial Results

WINNIPEG, Manitoba, May 26, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology...

KNE.VN : 0.100 (unch)
KNBIF : 0.0718 (-8.65%)
Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow

WINNIPEG, Manitoba, May 19, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology...

KNE.VN : 0.100 (unch)
KNBIF : 0.0718 (-8.65%)
Kane Biotech Obtains ISO 13485 Certification

The quality management system of Kane is certified for design and development of medical devices...

KNE.VN : 0.100 (unch)
KNBIF : 0.0718 (-8.65%)
Kane Biotech Announces Closing of Private Placement

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 17, 2022 (GLOBE NEWSWIRE) --...

KNBIF : 0.0718 (-8.65%)
KNE.VN : 0.100 (unch)
Kane Biotech Announces Update on Private Placement

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 06, 2022 (GLOBE NEWSWIRE) -- Kane Biotech...

KNE.VN : 0.100 (unch)
KNBIF : 0.0718 (-8.65%)
Kane Biotech Announces Extension of Private Placement Offering

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, April 29, 2022 (GLOBE NEWSWIRE) -- Kane...

KNBIF : 0.0718 (-8.65%)
KNE.VN : 0.100 (unch)
STEM Animal Health Awarded Veterinary Oral Health Council (VOHC) Seal of Acceptance for Pet Oral Care Water Additive

Certification further validates Kane’s coactiv+™ anti-biofilm technology. ...

KNE.VN : 0.100 (unch)
KNBIF : 0.0718 (-8.65%)
Kane Biotech Announces Fourth Quarter and Full Year 2021 Financial Results

WINNIPEG, Manitoba, March 24, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced its...

KNE.VN : 0.100 (unch)
KNBIF : 0.0718 (-8.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.115
2nd Resistance Point 0.110
1st Resistance Point 0.105
Last Price 0.100
1st Support Level 0.095
2nd Support Level 0.090
3rd Support Level 0.085

See More

52-Week High 0.140
Fibonacci 61.8% 0.106
Last Price 0.100
Fibonacci 50% 0.095
Fibonacci 38.2% 0.084
52-Week Low 0.050

See More

Business Summary

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar